DoD Peer Reviewed Cancer Idea Award with Special Focus

Archived

Defense Health Agency Contracting Activity - DHACA

Description

The Idea Award with Special Focus supports innovative, untested, high-risk/potentially high-reward concepts, theories, paradigms, and/or methods in cancer research that are relevant to Service members, their families, Veterans, and other military beneficiaries. The “Special Focus” of this award mechanism is on exposures, conditions, or circumstances that are unique to the military, disproportionately represented in a military beneficiary population, or may affect mission readiness. Cancers or circumstances with cancer risk that may affect military families are of special importance to the care and well-being of the military for total mission readiness. The advancement of knowledge in cancer research, patient care, and/or treatment options in the military health system is critical to active duty Service members, their families, Veterans, other military beneficiaries, and the American public. Military relevance should be articulated with respect to the overall military healthcare system, the FY16 PRCRP Military Relevance Focus Areas, and the mission of the DHP and the FY16 PRCRP. For more information, review the following websites: Military Health System (http://www.health.mil), Department of Veterans Affairs (http://www.va.gov/), the PRCRP (http://cdmrp.army.mil/prcrp/default.shtml), and PRCRP Report to Congress (http://cdmrp.army.mil/prcrp/reports/reports.shtml). The Idea Award with Special Focus is not intended to support a logical progression of an already established research project. The proposed research approach should be innovative. Innovative research may introduce a new paradigm, challenge existing paradigms, look at existing problems from new perspectives, or exhibit other highly creative qualities. The proposed research project should include a well-formulated, testable hypothesis based on strong scientific rationale and study design. Inclusion of preliminary data is not required. The outcome of research supported by this award should be the generation of robust preliminary data that can be used as a foundation for future research projects to understand the mechanisms of initiation or progression of cancer, the quality of life during and following cancer treatment, etc. This award is not intended to support ongoing research in the applicant’s laboratory; therefore, inclusion of preliminary data other than serendipitous findings or in very small amounts is not consistent with the exploratory nature of this award.

Who can apply

  • Unrestricted

Contact

CDMRP Help Desk <br/>Phone: 301-682-5507 <br/>Email: help@eBRAP.org
help@eBRAP.org

Key dates & funding
  • PostedApr 18, 2016
  • ClosesSep 13, 2016
  • Program funding$13,440,000
  • Expected awards21
  • CFDA12.420

Pro insight

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.

Unlock with Pro